Hopewell J W, Robbins M E, van den Aardweg G J, Morris G M, Ross G A, Whitehouse E, Horrobin D F, Scott C A
Research Institute (University of Oxford), Churchill Hospital, UK.
Br J Cancer. 1993 Jul;68(1):1-7. doi: 10.1038/bjc.1993.276.
The ability of essential fatty acids (EFAs) to modulate radiation-induced normal tissue injury was assessed in pig skin. Female Large White pigs (approximately 25 Kg) received 3 ml/day orally of either an 'active' oil [So-1100, containing 9% gamma-linolenic acid (GLA)] or a 'placebo' oil (So-1129) for just 4 weeks before or for 4 weeks before and for 16 weeks after irradiation; localised irradiation of skin was with single doses of beta-rays from 22.5 mm diameter 90Sr/90Y plaques. The severity of the acute reaction, assessed in terms of erythema or moist desquamation, was significantly less in those pigs that received So-1100 both before and after irradiation, as compared with those receiving that oil only prior to irradiation and the 'placebo' groups. Dose modification factors (DMFs) of between 1.13-1.24 were obtained. A similar reduction in the severity of acute skin injury was seen in pigs receiving So-1100 for only 10 weeks after irradiation. Late skin damage, assessed in terms of late erythema or dermal necrosis, was also reduced with So-1100, with DMFs of 1.14-1.51. No such modification was observed if So-1100 was only administered for 4 weeks prior to irradiation. No adverse side-effects were apparent as a result of EFA administration. So-1100 may represent a safe and valuable method of increasing the therapeutic gain in radiotherapy.
在猪皮肤中评估了必需脂肪酸(EFA)调节辐射诱导的正常组织损伤的能力。雌性大白猪(约25千克)在照射前4周或照射前4周及照射后16周,每天口服3毫升“活性”油[So-1100,含9%γ-亚麻酸(GLA)]或“安慰剂”油(So-1129);皮肤局部照射采用直径22.5毫米的90Sr/90Y斑块产生的单剂量β射线。与仅在照射前接受该油的猪和“安慰剂”组相比,在照射前后都接受So-1100的猪中,根据红斑或湿性脱屑评估的急性反应严重程度明显更低。获得了1.13 - 1.24之间的剂量修正因子(DMF)。在照射后仅接受So-1100 10周的猪中,也观察到急性皮肤损伤严重程度有类似降低。根据晚期红斑或皮肤坏死评估的晚期皮肤损伤,使用So-1100也有所减轻,DMF为1.14 - 1.51。如果So-1100仅在照射前给药4周,则未观察到这种修正。给予EFA未出现明显的不良副作用。So-1100可能是一种安全且有价值的提高放射治疗中治疗增益的方法。